CoChat

Diabetes, Active Disease, and Afternoon Serum Cortisol Levels Predict Cushing’s Disease Mortality: A Cohort Study

Open access
Roldán-Sarmiento, Paola, Lam-Chung, César Ernesto, Hinojosa-Amaya, José Miguel, Morales-García, Mariana, Guillén-Placencia, María Fernanda, Pérez-Flores, Greta E, León-Suárez, Andrés, León-Domínguez, Jefsi, Balbuena-Álvarez, Salvador, Nava de la Vega, Alfredo, Pérez-Guzmán, Citlalli Mireya, Gómez-Sámano, Miguel Ángel, Enríquez-Estrada, Víctor, Gómez-Pérez, Francisco J, Cuevas-Ramos, Daniel · 2021 · The Journal of Clinical Endocrinology & Metabolism
Cited by 25

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Context: Cushing’s disease (CD) is a life-threating disease, with increased mortality in comparison with the general population. Objective: This study aimed to evaluate standardized mortality ratios (SMRs) in CD patients. We also analyzed independent risk factors related to increased mortality. Design: We conducted a longitudinal cohort study in a 3rd level specialty center, from 1979 to 2018, in patients with CD. Results: From 1375 cases with a pathology diagnosis of pituitary adenoma, 191 cases had the confirmed diagnosis of CD (14%). A total of 172 patients completed follow-up, with a mean age at diagnosis of 33 ± 11 years, female predominance (n = 154, 89.5%), majority of them with microadenoma (n = 136, 79%), and a median follow-up of 7.5 years (2.4–15). Eighteen patients (10.5%) died, 8 of them (44%) were with active CD, 8 (44%) were under remission, and 2 (11%) were under disease control. Estimated all-cause SMR = 3.1, 95% confidence interval (CI) 1.9–4.8, P < 0.001. Cardiovascular disease was the main cause of death (SMR = 4.2, 1.5–9.3, P = 0.01). Multivariate Cox regression models adjusted for potential cofounders showed that diabetes (HR = 5.2, IC 95% 1.8–15.4, P = 0.002), high cortisol levels after 1600 hours at diagnosis (3.4, 2.3–7.0, P = 0.02), and active CD (7.5, 3.8–17.3, P = 0.003) significantly increased the risk of mortality. Conclusions: Main cause of CD mortality was cardiovascular disease. Main risk factors for mortality were uncontrolled diabetes, persistently high cortisol levels after 1600 hours at diagnosis, and active disease at last follow-up.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaa774

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 25

  1. Suarez, 2020, Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study, J Endocr Soc., 4, bvz033, 10.1210/jendso/bvz033 · DOI · Paper page
  2. Wagner, 2018, Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing’s syndrome: a systematic meta-analysis, Front Endocrinol (Lausanne)., 28, 1
  3. Ferraù, 2015, Metabolic comorbidities in Cushing’s syndrome, Eur J Endocrinol., 173, M133, 10.1530/EJE-15-0354 · DOI · Paper page
  4. Swearingen, 1999, Long-term mortality after transsphenoidal surgery for Cushing disease, Ann Intern Med., 130, 821, 10.7326/0003-4819-130-10-199905180-00015 · DOI · Paper page
  5. Alexandraki, 2013, Long-term remission and recurrence rates in Cushing’s disease: predictive factors in a single-centre study, Eur J Endocrinol., 168, 639, 10.1530/EJE-12-0921 · DOI · Paper page
  6. Yap, 2002, Undetectable postoperative cortisol does not always predict long-term remission in Cushing’s disease: a single centre audit, Clin Endocrinol (Oxf)., 56, 25, 10.1046/j.0300-0664.2001.01444.x · DOI · Paper page
  7. van Haalen, 2015, Management of endocrine disease: mortality remains increased in Cushing’s disease despite biochemical remission: a systematic review and meta-analysis, Eur J Endocrinol., 172, R143, 10.1530/EJE-14-0556 · DOI · Paper page
  8. Lambert, 2013, Predictors of mortality and long-term outcomes in treated Cushing’s disease: a study of 346 patients, J Clin Endocrinol Metab., 98, 1022, 10.1210/jc.2012-2893 · DOI · Paper page
  9. Colao, 1999, Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure, J Clin Endocrinol Metab., 84, 2664
  10. Loriaux, 2017, Diagnosis and differential diagnosis of Cushing’s syndrome, New Engl J Med., 376, 1451, 10.1056/NEJMra1505550 · DOI · Paper page
  11. van den Bogaert, 1999, The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing’s syndrome, Clin Endocrinol (Oxf)., 51, 193, 10.1046/j.1365-2265.1999.00759.x · DOI
  12. Boscaro, 2009, Approach to the patient with possible Cushing’s syndrome, J Clin Endocrinol Metab., 94, 3121, 10.1210/jc.2009-0612 · DOI · Paper page
  13. Liddle, 1960, Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome, J Clin Endocrinol Metab., 20, 1539, 10.1210/jcem-20-12-1539 · DOI · Paper page
  14. Boscaro, 1992, Selective venous sampling in the differential diagnosis of ACTH-dependent Cushing’s syndrome, Neuroendocrinology., 55, 264, 10.1159/000126124 · DOI
  15. Pikkarainen, 1999, The survival and well-being of patients treated for Cushing’s syndrome, J Intern Med., 245, 463, 10.1046/j.1365-2796.1999.00483.x · DOI · Paper page
  16. Jagannathan, 2007, Evaluation and management of Cushing syndrome in cases of negative sellar magnetic resonance imaging, Neurosurg Focus., 23, 1, 10.3171/foc.2007.23.3.4 · doi:10.3171/foc.2007.23.3.4
  17. Barber, 2010, Nelson’s syndrome, Eur J Endocrinol., 163, 495, 10.1530/EJE-10-0466 · DOI
  18. Graversen, 2012, Mortality in Cushing’s syndrome: a systematic review and meta-analysis, Eur J Intern Med., 23, 278, 10.1016/j.ejim.2011.10.013 · DOI
  19. Ljubijankić, 2008, Daily fluctuation of cortisol in the saliva and serum of healthy persons, Bosn J Basic Med Sci., 8, 110, 10.17305/bjbms.2008.2962 · DOI
  20. Papanicolaou, 1998, A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states, J Clin Endocrinol Metab., 83, 1163
  21. Carroll, 2010, The diagnosis of Cushing’s syndrome, Rev Endocr Metab Disord., 11, 147, 10.1007/s11154-010-9143-3 · DOI
  22. Espinosa-de-Los-Monteros, 2017, Long-term outcome of the different treatment alternatives for recurrent and persistent Cushing disease, Endocr Pract., 23, 759, 10.4158/EP171756.OR · DOI
  23. Patil, 2008, Outcomes after repeat transsphenoidal surgery for recurrent Cushing’s disease, Neurosurgery., 63, 266, 10.1227/01.NEU.0000313117.35824.9F · DOI · Paper page
  24. Ironside, 2018, Earlier post-operative hypocortisolemia may predict durable remission from Cushing’s disease, Eur J Endocrinol., 178, 255, 10.1530/EJE-17-0873 · DOI
  25. Yamada, 2015, Therapeutic outcomes in patients undergoing surgery after diagnosis of Cushing’s disease: a single-center study, Endocr J., 62, 1115, 10.1507/endocrj.15-0463 · DOI

Cited by

See all 25

Metadata

Authors
Roldán-Sarmiento, P., Lam-Chung, C. E., Hinojosa-Amaya, J. M., Morales-García, M., Guillén-Placencia, M. F., Pérez-Flores, G. E., León-Suárez, A., León-Domínguez, J., Balbuena-Álvarez, S., Nava de la Vega, A., Pérez-Guzmán, C. M., Gómez-Sámano, M. Á., Enríquez-Estrada, V., Gómez-Pérez, F. J., & Cuevas-Ramos, D.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2020-10-28
Volume
106
Issue
1
Pages
e103-e111
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3097439661
Cited by
25
References
13
FWCI
2.87
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.